neonatal intensive care therapies
2 articoli — 2005-2021
RI
Ricerca
Le priorità associate all’uso dei farmaci “off-label”
F. Marchetti, J. Bua, S. Demarini, et al.
2005/8 — pag. 527-531
Argomenti correlati
Adrenal Cortex Hormones (256)
Children (127)
Neonatal Screening (123)
Autism Spectrum Disorder (89)
Corticosteroidi (78)
Corticosteroids (72)
Immunosuppressive Agents (41)
Anticonvulsants (39)
Self-Injurious Behavior (35)
Off-Label Use (33)
Birth Rate (31)
Hearing Loss (30)
COVID-19 Vaccines (30)
Cytomegalovirus Infections (29)
Language development (26)
Midazolam (24)
Drug Approval (22)
Farmaci pediatrici (20)
Pediatric drugs (17)
Hospitals, Pediatric (16)
